Coverage of generic inhalers (albuterol HFA)
Customize your policy alerts
Sign up for all kernfamilyhealthcare policy alerts
Know when kernfamilyhealthcare releases new policies or updates existing guidance.
Monitor payer policy activity
This document notifies providers that Kern Family Health Care covers generic versions of the three branded albuterol HFA inhalers (Ventolin HFA, ProAir HFA, Proventil HFA) and describes emergency 72-hour dispensing procedures; it applies to KFHC providers and pharmacies.
No material clinical or coverage changes in this revision.
Coverage Criteria
Generic inhaler coverage
Covered
Emergency supply criteria
Emergency supply allowed when ALL conditions are met
A Treatment Authorization Request (TAR) documenting the emergency dispensing event is required. If a KHS nurse gives verbal authorization to the pharmacy, the verbal authorization will be honored but may require clearance on the next working business day.
KFHC does not list any specific exclusions for coverage of generic albuterol HFA inhalers. The policy states plainly that KFHC covers all generic versions of the three branded products: Ventolin HFA, ProAir HFA, and Proventil HFA, and does not enumerate exceptions to that coverage in the source document.
None stated.
Provider Actions and Requirements
Prior authorization: routine vs emergency supply
No routine prior authorization is required for generic versions of Ventolin HFA, ProAir HFA, and Proventil HFA; however, when an emergency 72-hour supply is dispensed a TAR documenting the emergency must be submitted after dispensing.
Step therapy not required
There are no step therapy requirements described in this policy for generic albuterol HFA inhalers.
TAR required for 72-hour emergency supply
A Treatment Authorization Request (TAR) documenting the emergency dispensing event is required when a 72-hour emergency supply is authorized.
Denial risk if TAR or emergency details are missing
If a TAR documenting the emergency dispensing is not provided, authorization for the emergency 72-hour supply may not be supported; documentation should show the emergent circumstance and, if applicable, any verbal KHS nurse authorization and timing.
- Emergency supply is limited to up to a 72-hour supply and must be for a truly emergent situation.
- Verbal authorization from a KHS nurse will be honored temporarily but may require next business day clearance — include this in documentation when applicable.
Definitions
Quantity Limits
Site of Care / Dispensing Location
Pharmacy emergency dispensing — verbal nurse authorization accepted; TAR required after dispensing
Pharmacies may honor a verbal authorization from a KHS nurse to dispense an emergency 72‑hour supply, but a TAR documenting the dispensing will be required (the verbal authorization may require next business day clearance).
Background
Albuterol HFA inhalers (examples cited in the policy: Ventolin HFA, ProAir HFA, Proventil HFA) are short-acting beta-agonist inhalers used for relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease. The policy notifies providers that the FDA has approved a generic version of Proventil HFA and that KFHC covers all generic versions of the three branded drugs, increasing formulary options for short-acting bronchodilator therapy.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.